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Abstract: Macrodomains, enzymes that remove ADP-ribose from proteins, are encoded by several
families of RNA viruses and have recently been shown to counter innate immune responses to virus
infection. ADP-ribose is covalently attached to target proteins by poly-ADP-ribose polymerases
(PARPs), using nicotinamide adenine dinucleotide (NAD+) as a substrate. This modification can
have a wide variety of effects on proteins including alteration of enzyme activity, protein–protein
interactions, and protein stability. Several PARPs are induced by interferon (IFN) and are known to
have antiviral properties, implicating ADP-ribosylation in the host defense response and suggesting
that viral macrodomains may counter this response. Recent studies have demonstrated that viral
macrodomains do counter the innate immune response by interfering with PARP-mediated antiviral
defenses, stress granule formation, and pro-inflammatory cytokine production. Here, we will describe
the known functions of the viral macrodomains and review recent literature demonstrating their roles
in countering PARP-mediated antiviral responses.
Keywords: ADP-ribose; macrodomain; PARPs; stress granule; ADP-ribosylation; RNA virus;
alphaviruses; coronaviruses; hepatitis E virus
1. Identification of Viral Macrodomains
Viral macrodomains are small protein domains of about 15–20 kDa encoded within the
nonstructural proteins of several RNA viruses. Computer-assisted comparisons of RNA viruses in the
early 1990s identified a conserved region of known function in the polyproteins of the Coronaviridae,
Togaviridae, Matonaviridae, and Hepeviridae families which was named the “X” domain [1,2].
Eventually, the “X” domain was renamed macrodomain based on the protein folding that appear
to be similar to the “macro” part of the macroH2A protein. The macrodomain is encoded within
nonstructural protein 3 (nsP3) of the coronaviruses and alphaviruses and within open reading
frame 1 (ORF1) of the rubella virus and hepatitis E virus. Several crystal structures of alphavirus and
coronavirus macrodomains have been determined and demonstrate a highly conserved α/β/α sandwich
fold [3,4]. The biochemical function of viral macrodomains were ambiguous until the discovery that
viral macrodomains are enzymatically active and bind to poly- and mono-ADP-ribose [4–7]. Viral
macrodomains were originally shown to have ADP-ribose-1”-phosphatase activity, removing phosphate
from ADP-ribose-1”-phosphate. However, more recently, it has been demonstrated that they have
hydrolase activity that removes ADP-ribose from proteins (Figure 1) [8,9].
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Figure 1. A schematic representation of the ADP-ribosylation and de-ADP-ribosylation by the viral
macrodomains: The crystal structures of the poly-ADP-ribose polymerase (PARP)-12 protein [10] were
downloaded from the protein data bank (PDB) (doi:10.2210/pdb2PQF/pdb), and the Venezuelan
equine encephalitis virus (VEEV) macrodomain structure [11] was downloaded from the PDB
(doi:10.2210/pdb5mqx/pdb).
2. ADP-Ribosylation and the Innate Immune Response
ADP-ribosylation is a posttranslational modification where ADP-ribose molecules are covalently
attached to target proteins at one of several different amino acids including glutamate, aspartate, cysteine,
lysine, arginine, and serine [12,13]. Additionally, it has been shown that ADP-ribose molecules can be
added to nucleic acids [14]. The ADP-ribose is transferred from nicotinamide adenine dinucleotide
(NAD+) onto target proteins as a single molecule of ADP-ribose (mono-ADP-ribose (MAR)) [8] or
as consecutive individual units to form polymers of ADP-ribose molecules (poly-ADP-ribose (PAR))
by ADP-ribosyl transferases (ARTs) including the poly-ADP-ribose polymerases (PARPs) [15]. There
are 17 known PARPs in the human genome, and more than half of them are induced by interferon
(IFN), implicating ADP-ribose in the antiviral defense system. When IFN binds to its receptor, the
IFN α/β receptor (IFNAR), it initiates a signaling cascade that results in the transcription of hundreds
of interferon-stimulated genes (ISGs), many of which have antiviral activities. PARPs have many
well-known pro- and antiviral activities (reviewed in Reference [16]). For instance, PARP12 is required
for the ADP-ribosylation of Zika virus proteins NS1 and NS3 that inhibit Zika virus replication [17].
Conversely, PARP7 ADP-ribosylates TBK-1 which inhibits IFN production and leads to enhanced
replication of influenza virus [18].
3. ADP-Ribose Binding and Hydrolase Activities of the Viral Macrodomains
ADP-ribosylation is a reversible modification via several enzymes that belong either to the
ADP-ribosylglycohydrolase (DraG-like) family or to the macrodomain family [19]. Some of these
enzymes hydrolyze a single unit of MAR, whereas the poly-ADP-ribose glycohydrolases (PARGs) can
remove polymers of ADP-ribose molecules at O-glycosidic bonds [20–23]. It has been described that
these enzymes hydrolyze ADP-ribose from target proteins at specific amino acid positions [24]. Human
macroD2 enzymes, for instance, remove ADP-ribose from MARylated proteins at glutamate-ADP-ribose
linkages [20,21]. Sequence analysis of viral macrodomains place them in the macroD2 family (Figure 2)
and suggests that de-MARylation may be the primary enzymatic activity of the viral macrodomains [8].
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Figure 2. Sequence alignment of the amino acid sequences of various viral macrodomains from
coronaviruses, alphaviruses, rubellavirus, and hepatitis E virus: The human macroD2 protein sequence
was included for comparison. Sequences of viral and human macrodomains were alignment using
CLC Genomics Workbench software. Arrows indicate residues that are discussed in the text.
Early structural data demonstrated that macrodomains, including viral macrodomains, are
ADP-ribose-binding proteins [3,4,7]. They bind to both MAR and PAR, though the Hepatitis E virus
(HEV) macrodomain required the inclusion of the downstream helicase domain of ORF1 to bind
PAR [8]. Comparisons of ADP-ribose binding between the cellular and viral macrodomains were
described in several studies [3,4,7] and, thus, will not be extensively discussed here. However, we will
discuss some of the basic principles of ADP-ribose binding and hydrolysis by viral macrodomains.
First, as stated above, all viral macrodomains can bind to both MAR and PAR. These enzymes are
efficient erasers of MAR but are less efficient at removing PAR [8,9]. It is yet unclear which of these
activities play a dominant role during virus infections, but current data suggests that de-MARylation is
their primary function. Data from McPherson et al., Abraham et al., and Fehr et al. support this idea as
these studies demonstrated a correlation between de-MARylating activity and virus replication in cell
culture and pathogenesis in vivo [25–27]. Also, the IFN-inducible PARPs are mono-ADP-ribosylating
PARPs, again suggesting that viral macrodomains likely act to counter this antiviral response. However,
it is also conceivable that MAR and PAR may work together in the antiviral response, as PARylation of
Zika virus proteins has been observed, which is dependent on PARP12 activity. However, it is not clear
how the MARylating activity of PARP12 is connected to the PARylation of Zika virus proteins [17].
Mutagenesis studies have identified several conserved residues within the macrodomain that
impact ADP-ribose binding and/or enzymatic activity (summarized in a previous review [28]). Most
notably, the distal ribose is tightly coordinated by two distinct loop regions that are highly conserved.
Loop 1 includes a highly conserved triple glycine motif that interacts with the α-phosphate and the 1”
and 2” OH groups of the distal ribose. Loop 2 contains a highly conserved GIF (Coronaviruses (CoVs))
or GIY (Togaviruses) motif that primarily contacts the β-phosphate of ADP-ribose and provides van
der Waals contacts to direct the orientation of the distal ribose. A recent NMR structure, which depicted
ADP-ribose bound and unbound forms of the VEEV macrodomain, showed that these loops undergo a
dramatic conformational shift upon encountering ADP-ribose [11]. This is especially true for loop 1,
which moved close to 3Å during this transition. A highly conserved asparagine residue (N41 in severe
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acute respiratory syndrome (SARS)-CoV) also appears to help coordinate the distal ribose, while an
aspartic acid (D23 in SARS-CoV) provides hydrogen bonds to contact the amino group of the adenine.
However, this aspartic acid is not completely conserved, as a serine or asparagine can provide these
contacts in some alphaviruses (Figure 2).
The mechanism of de-ADP-ribosylation is not fully understood but likely involves the proper
coordination of the protein-ADP-ribose bond near a conserved catalytic water molecule that can
complete hydrolysis of the bond. The chikungunya virus (CHIKV) macrodomain was only able to
hydrolyze ADP-ribose from acidic residues, indicating that viral macrodomains may only be able
to cleave ester bonds. A mutation in loop 2 has been identified in both CHIKV and Sindbis virus
(SINV), Y114A, that has reduced hydrolysis but increased ADP-ribose binding activity, indicating that
this residue may be specifically important for hydrolysis. These mechanisms may not be identical
between CoVs and alphaviruses, as they are phylogenetically distinct (Figure 3). Additional structural
and mutagenesis studies will be needed to determine the precise mechanism of hydrolysis for
macrodomain proteins.
Figure 3. Phylogenetic tree of the viral macrodomains proteins sequences constructed with the neighbor
joining method using Geneious Bioinformatics software.
4. The Role of Macrodomains in Virus Replication In Vitro and In Vivo
The impact of viral macrodomains in viral replication and pathogenesis has been extensively
examined over recent years, utilizing reverse genetic systems for multiple alphaviruses, coronaviruses,
and HEV. Here, we will briefly discuss the results from each viral family that has been tested.
4.1. Hepatitis E Virus
HEV is the sole member of the Hepeviridae family and is a non-enveloped positive-sense RNA
virus with 3 ORFs. It is an emerging pathogen and possibly the most common cause of acute viral
hepatitis in the world, with up to 3 million infections per year. HEV infection can lead to chronic
hepatitis and cirrhosis and can cause stillbirths of the fetus in pregnant women [29]. The ORF1
polyprotein of HEV contains multiple domains, including the macrodomain, which is adjacent to RNA
helicase domain. Interestingly, the RNA helicase domain was shown to be important for the ability
of the macrodomain to bind and hydrolyze PAR and MAR [8]. HEV replicates poorly in cell culture,
so reverse genetic systems for this virus have largely utilized replicon systems where HEV replicon
plasmids containing a reporter construct are transfected into Huh-7 cells. Parvez tested the role of the
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HEV macrodomain during infection using a replicon with a GFP reporter and found that mutations in
loop 1 and loop 2 and in the highly conserved asparagine residue eliminated GFP expression, while
Li et al., using a luciferase reporter, also found that similar mutations in these same regions reduced
luciferase activity [8,30]. These studies indicate that the HEV macrodomain is likely important for
virus replication, though it would be of interest to determine its impact using virus replication systems
for HEV, which are limited at this time.
4.2. Alphaviruses
Alphaviruses are enveloped, positive-sense RNA viruses and are prominent arboviruses that
replicate in both vertebrate and invertebrate hosts. This family of viruses include human pathogens
such as CHIKV, Ross River Virus (RRV), and Venezuelan equine encephalitis virus (VEEV). These viruses
can cause a number of different pathologies, with severe arthritis or rash being the most common.
The first studies on the role of the alphavirus macrodomain were in SINV, where viruses with
mutations in highly conserved asparagine residues replicated normally in baby hamster kidney 21
(clone-13 cells) (BHK-21 cells) but were highly attenuated in vivo [31]. A more recent study using
additional mutations in the catalytic hydrolase loop (N24 and G32) of the SINV macrodomain (Figure 4)
came to similar conclusions while also showing that mutations that have reduced hydrolase and that
binding activities replicate poorly or quickly revert in mouse neuronal cells. In addition, a Y114A
mutation had slightly greater innate responses in the nervous system [32].
In slight contrast, CHIKV macrodomain mutations have severe effects on virus replication in all
cell types [25]. Several recombinant viruses containing mutations that significantly affect hydrolase
and binding activities were unrecoverable in BHK cells, as they quickly reverted back to wild-type
sequence. A loop 1 mutant (G32E) even reverted following transfection into a mosquito cell line,
indicating that antiviral ADP-ribosylation occurs in mosquito cells as well. To study the impact of the
macrodomain in CHIKV infection, the authors made more subtle mutations in the macrodomain that
allowed for the recovery of mutant viruses (G32S, G32A, T111A, and Y114A). While these mutants
were only partially defective in hydrolase or ADP-ribose binding, they were severely attenuated in cell
culture and in mice, demonstrating the incredible ability of ADP-ribosylation to restrict the replication
of alphaviruses. Importantly, the Y114A mutation in SINV and CHIKV had reduced hydrolase activity
but enhanced ADP-ribose-binding abilities. While attenuated compared to wild-type virus, this mutant
was significantly more virulent than other mutations with similar hydrolase activity, indicating distinct
roles for ADP-ribose binding and hydrolysis in pathogenesis.
G32S and Y114A were further utilized to identify the impact of ADP-ribose binding and hydrolase
activities in the viral lifecycle [26]. The Y114A mutant virus, which only lacks hydrolase activity,
initiated infection normally and produced similar levels of viral RNA and proteins compared to
wild-type virus. However, these processes were dramatically reduced following infection of the G32S
mutant virus, which is also defective in binding. This indicates that ADP-ribose binding but not
hydrolysis activity is critical for early stages of the viral lifecycle. The lack of a defect in viral protein
production but a significant drop in viral titers following infection with Y114A indicates that hydrolase
activity may have a more substantial impact on later stages of the virus replication cycle.
More recently, it was shown that mutations V33E and D10A of the CHIKV macrodomain, which
likely impair both ADP-ribose binding and hydrolysis [9,25], affected polyprotein processing by the
nsP2 protease. In vitro, it was shown that the protease could be ADP-ribosylated by PARP10, that
protease activity was altered by ADP-ribosylation, and that the macrodomain could reverse this
modification [33]. It will be of great interest to determine if nsP2 is ADP-ribosylated during infection.
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Figure 4. The crystal structure of the VEEV macrodomain protein [11] was downloaded from the PDB
(doi:10.2210/pdb5mqx/pdb): Highlighted residues are D21 (blue, D20 in chikungunya virus (CHIKV));
N35 (black, N34 in CHIKV); G33 (red, G32 in CHIKV); T112 (yellow, T111 in CHIKV); and F115 (purple,
Y114 in CHIKV). ADP-ribose (ADPR) is also shown.
4.3. Coronaviruses
Coronaviruses (CoVs) are large, enveloped, positive-sense RNA viruses that cause a variety of
diseases in humans and veterinary animals [34]. Human CoVs, such as hCoV-229E, cause ~10%–30%
of common cold cases but, until the early 2000s, were not thought to cause serious diseases in humans.
However, in the past 2 decades, 3 new pathogenic CoVs have emerged in China and the Middle East
that cause deadly human infections. These include the severe acute respiratory syndrome (SARS)-CoV,
Middle East respiratory syndrome (MERS)-CoV, and the ongoing pandemic outbreak of SARS-CoV-2.
The coronaviruses macrodomain is located within nsp3, and its role in replication or pathogenesis
has been analyzed in hCoV-229E, murine hepatitis virus (MHV), SARS-CoV, and infectious bronchitis
virus (IBV). Most studies of the CoV macrodomain utilize mutation of the highly conserved asparagine
residue (N41-SARS-CoV) to alanine, which has been shown to ablate both the phosphatase and
hydrolase activity of the macrodomain [4,5,27]. Normal virus replication in cell culture was observed in
almost all cases, including hCoV-229E infection of human fetal lung fibroblast cells (MRC-5 cells) [5]; IBV
infection of chicken kidney and chicken embryonic fibroblasts [35]; MHV-A59 infection of peritoneal
macrophages, Kupffer cells, dendritic cells, and L929 cells [36]; MHV-A59 and MHV-JHM (two distinct
strains of MHV) infection of 17CL-1 cells [36,37]; and SARS-CoV infection of Vero and Calu-3 cells (a
bronchial epithelial cell line) [27,38]. In addition, the complete deletion of the SARS-CoV macrodomain
did not significantly affect luciferase expression in a SARS-CoV replicon [39]. These results indicate
that the hydrolase activity of the macrodomain is not a general requirement for CoV replication.
However, the MHV-JHM asparagine-to-alanine mutation (N34A) replicated poorly in
bone-marrow-derived macrophages (BMDMs) [40]. BMDMs are primary cells that elicit a robust
innate immune response, indicating that the macrodomain may function to counter the innate antiviral
immunity. Consistent with this idea, the MHV-JHM, SARS-CoV, and hCoV-229E mutant viruses
were sensitive to interferon (IFN) pretreatment and the replication of the MHV-JHM mutant virus
could be restored in IFN α/β receptor knockout (IFNAR−/−) cells, which are unable to respond to IFN
treatment [38].
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Coronavirus macrodomain mutant viruses are also highly attenuated in vivo. Both MHV and
SARS-CoV mutants were found to cause minimal disease in mice [27,36,37], and these mutants also
had significantly reduced titers in their target organs (liver or brain for MHV and lungs for SARS-CoV).
To further implicate the innate immune response in the attenuation of these viruses, the MHV-JHM
mutant virus caused severe disease upon either depletion of microglia in the brain or upon infection
of mice lacking the ability to respond to interferon (IFNAR−/−) [40,41]. These results demonstrate
that the hydrolase activity of the CoV macrodomain is largely dispensable for virus replication but is
clearly required for pathogenesis and likely promotes virulence by countering the mammalian innate
immune response.
Furthermore, the CoV macrodomain has been shown to also inhibit the production of IFN
during certain infections. The SARS-CoV macrodomain mutant virus elicited a strong IFN and
pro-inflammatory cytokine response in the lungs of infected mice during the early stages of infection
and following infection of Calu-3 cells [27]. Using a coinfection model, it was shown that the increased
cytokine response was partially responsible for the attenuation of this virus in vivo. Similarly, the
MHV-JHM macrodomain mutant virus also led to a dramatic induction of IFN in BMDMs, while the
MHV-A59 mutant virus also lead to increased production of IFN in plasmacytoid dendritic cells [36,40].
It remains unclear how hydrolase activity inhibits cytokine production.
Finally, a recent paper by Deng et al. showed that the MHV macrodomain and the PLP2 domain
(protease and deubiquitinase (DUB)) can physically interact with each other [42]. Temperature-sensitive
mutants were identified in the macrodomain that decreased the stability of PLP2 and nsP3 and negatively
regulated replication and pathogenesis of MHV. Both domains regulate IFN production, and a direct
interaction indicates that they may either regulate the same protein(s) that are dually regulated
by ubiquitination and ADP-ribosylation or perhaps that the protease is ADP-ribosylated and this
modification needs to be removed for its function.
5. PARPs Enhance IFN Production and Can Restrict Coronavirus Replication Following
Macrodomain Mutant Virus Infection
While PARP enzymes were the likely mediators of antiviral ADP-ribosylation, other enzymes
can ADP-ribosylate proteins. To determine that PARPs were indeed inhibiting MHV infection in
the absence of the macrodomain, wild-type (WT) and mutant virus-infected BMDMs were treated
with PARP inhibitors (3-AB and XAV-939), both of which can inhibit multiple PARPs, including both
PARylating and MARylating PARPs [43]. These inhibitors substantially increased the replication of the
macrodomain mutant virus without having any noticeable effect on the WT virus. Additionally, the
PARP inhibitors decreased the level of IFN-β production back to WT levels, further demonstrating that
PARP-mediated ADP-ribosylation plays a role in regulating IFN production during infection [40].
It is well known that PARPs are upregulated by IFN [44]. Recently, the expression of all 17
mammalian PARPs in BMDMs following MHV infection was examined to identify PARPs that could
potentially be involved in restricting its replication. Using quantitative RT-PCR, 7 of the 16 mouse
PARPs were highly expressed and dramatically upregulated following MHV infection. Their expression
was mostly absent in IFNAR−/− cells, consistent with their strong upregulation by IFN. To identify the
specific PARP(s) that inhibits virus replication, an siRNA screen was then performed. Knockdown
of both PARP12 and PARP14 partially restored mutant virus replication while having no impact on
wild-type virus. All other PARPs tested were unable to restore mutant virus replication. In addition,
PARP14 promoted IFN production during CoV infection or poly(I:C) treatment, consistent with
another study showing that PARP14 enhanced IFN production following treatment of macrophages
with lipopolysacharacide (LPS) stimulus [45]. These data are consistent with the hypothesis that
PARP12 and PARP14 are coronavirus restriction factors, but their functions are largely mitigated by
the viral macrodomain.
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6. The Alphavirus Macrodomain Can Block Stress Granule Formation
Stress granules (SGs) are non-membranous structures containing a mixture of RNA and protein
including stalled translation initiation complexes that form upon cellular stress. One of these types of
stress is viral infection. Early stages of many virus infections result in the formation of dsRNA that
can activate protein kinase R (PKR). PKR then phosphorylates eIF2α, blocking mRNA translation,
which then promotes the assembly of SGs [46]. These stress granules limit the amount of translation
factors available, which potently interferes with virus replication as all viruses require cellular
protein machinery to translate their proteins [47]. SGs are regulated by multiple different types
of posttranslational modifications, including ADP-ribosylation. As such, SGs contain several PAR
glycohydrolase isoforms, along with ADP-ribosylated proteins such as the RNA decay factor protein,
G3BP1. In addition, several PARPs has been identified within the stress granules (PARP-5a, PARP-12,
PARP-13, PARP14, and PARP-15); however, SG proteomes rarely identify all 5 of these PARPs, and so
PARP composition dynamics within SGs likely differ according to multiple factors including cell type
and type of stress [48–50].
Stress granule formation and disassembly are highly regulated during viral infection. Viruses
use different strategies to disrupt SGs, either by suppressing their formation or by promoting their
disassembly. Ebola virus, for instance, inhibits SG initiation through interactions of the C-terminal
domain of the VP35 protein with different components of the SGs including G3BP1, eIF3, and eEF2 [51].
However, in many cases, the mechanism of such action is unknown.
Alphaviruses, such as CHIKV, induce stress granule formation at the early stage of the viral
infection followed by the disassembly of SGs which is mainly influenced by nsP3 [52]. nsP3 contains
the macrodomain, a zinc-binding domain, and a C-terminal hypervariable region domain (HVD).
The hypervariable domain (HVD) was previously known to interact with G3BP1 and G3BP2, and thus,
it was proposed that this interaction results in sequestration of G3BP1/2 and SG disassembly [53–55].
However, a recent study reported that the HVD of CHIKV alone was unable to affect SG formation,
though it did interact with SGs. They did show that the full-length nsP3 was able to prevent the
accumulation of SGs, suggesting that another factor in nsP3 besides the HVD is involved in SG
disassembly. Interestingly, overexpression of the CHIKV macrodomain alone inhibited SG formation
induced by multiple cell stressors. This study further showed that hydrolase activity of the macrodomain
was required for the ability to disrupt SGs. Additionally, hydrolase activity was required to prevent
arsenite-induced SG formation during a CHIKV infection. Finally, the authors hypothesized that the
macrodomain could remove ADP-ribose from G3BP1, a critical factor for SG formation that is known
to be ADP-ribosylated. Upon overexpression of G3BP1 in 293F cells, ADP-ribosylation of G3BP1 could
be observed; however, this modification was lost upon overexpression of nsP3, suggesting that the
macrodomain can remove ADP-ribose from G3BP1 [56]. Interestingly, there was a clear distinction in
the composition of SGs that were disrupted by the macrodomain. The disrupted SGs still maintained
mRNA-binding proteins but lost all proteins involved in translation, indicating that the macrodomain
disrupts SGs in a specific manner. In conclusion, the results from this study show that SG formation
is dependent on the ADP-ribosylation of proteins within SGs and that the hydrolase activity by the
alphaviruses macrodomain is able to disassemble SGs.
7. Future Directions for Macrodomain Research
Studies from the past 15 years have clearly shown that viral macrodomains bind MAR- and
PARylated proteins and enzymatically hydrolyze ADP-ribose from proteins. More recently, it has
been demonstrated that macrodomains likely counter PARP activity, block IFN production, and
can disassemble stress granules. However, the biological processes and target proteins of viral
macrodomains remain largely unknown. Based on the evidence described here, it is clear that the
de-ADP-ribosylating activity of the macrodomain is critical for its functions. However, it cannot be
ruled out that some of these mutations discussed herein may impact other macrodomain functions,
such as nucleic acid binding, which could also impact virus replication.
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While the CHIKV macrodomain can de-ADP-ribosylate G3BP1 and the nsP2 protease when each
is overexpressed in mammalian cells or in vitro, it is unclear if these proteins are targeted by viral
macrodomains during infection. Macrodomains surely target multiple proteins due to the number of
different phenotypes associated with mutant viruses, so it will be of great interest to identify these
proteins, to determine what cellular processes are affected by ADP-ribosylation, and to ultimately
determine how ADP-ribosylation leads to inhibition of virus replication. However, finding these
targeted proteins is challenging due to the number and diversity of ADP-ribosylated proteins in cells.
Also, it should not be assumed that the functions of macrodomains from alphaviruses and CoVs or
even within these virus families will be similar. Their protein sequences are significantly different
(Figures 2 and 3), and these viruses use distinct mechanisms for their replication and pathogenesis.
There is more work to be done to identify PARPs that are mediating antiviral ADP-ribosylation
that is countered by macrodomains. PARP12 and PARP14 were identified as PARPs that could
restrict replication of macrodomain mutant MHV in BMDMs, but it is likely that other PARPs may be
important for different viruses or in different cell types. Identification of these PARPs may aid in the
identification of meaningful ADP-ribosylated targets. Knowing what PARPs are mediating antiviral
ADP-ribosylation may also lead to novel antiviral strategies.
It is also unclear whether the hydrolysis of MAR, PAR, or both is responsible for phenotypes
associated with macrodomain mutant viruses. Despite a large number of macrodomain structures,
the biochemistry of the macrodomain still requires further investigation to determine the mechanism
of hydrolysis. It is also unclear whether macrodomains have specificity for certain proteins. Many
in vitro assays for hydrolase activity utilize the de-ADP-ribosylation of auto-ADP-ribosylated PARP
proteins, indicating that the macrodomain may be able to de-ADP-ribosylate most proteins it can
interact with [8,9,25,27,32].
Finally, an intriguing question that remains is as follows: are macrodomains suitable targets for
antiviral therapeutics? Considering the significant attenuation seen with macrodomain mutants, it
seems that the answer is yes. However, humans also have macrodomains, so there is the potential for
significant side effects. It will be important to identify biochemical differences between human and viral
macrodomains, such that antiviral therapeutics could be developed that are highly specific for viral
macrodomains. Alternatively, these therapeutics could be useful in an agricultural setting for highly
virulent infections such as porcine epidemic diarrhea virus (PEDV)-infected pigs. As exemplified by
the recent SARS-CoV-2 outbreak, developing therapeutics targeting highly conserved viral proteins,
such as the macrodomain, could be a useful for creating an arsenal of drugs that could be deployed to
treat emerging alphavirus, hepatitis E, or coronavirus infections.
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